THE PHAGE to Exhibit and Co-Host Luncheon Seminar at the 69th Annual Meeting of the Japan Diabetes Society
THE PHAGE, Inc. will participate in the 69th Annual Meeting of the Japan Diabetes Society by exhibiting a booth and co-hosting a luncheon seminar. The company will present implementation cases and scientific evidence of its postprandial blood glucose management platform, "glucose flight®︎," aiming to solve challenges in behavioral change support for diabetes treatment.
📋 Article Processing Timeline
- 📰 Published: May 13, 2026 at 18:00
- 🔍 Collected: May 13, 2026 at 09:31
- 🤖 AI Analyzed: May 13, 2026 at 09:42 (10 min after Collected)
THE PHAGE, Inc. (Headquarters: Shibuya-ku, Tokyo; Representative Director: Shohei Tokunaga; hereinafter "the Company") announces its participation in the "69th Annual Meeting of the Japan Diabetes Society" (Theme: IMAGINE Aiming for a future where life shines: Together for diabetes medical care and science), to be held from Thursday, May 21st to Saturday, May 23rd, 2026, at the Osaka International Convention Center and Rihga Royal Hotel Osaka, through exhibiting a booth and co-hosting a luncheon seminar.
■ Background of Participation
In Japan, where approximately 10 million people are said to suffer from type 2 diabetes, optimizing HbA1c management is crucial. However, supporting behavioral changes to suppress postprandial hyperglycemia is also gaining attention as a vital pillar of treatment. Yet, visualizing patients' dietary habits and promoting continuous behavioral change within the time constraints of outpatient care remains a significant challenge.
Our "glucose flight®︎" platform integrates CGM (Continuous Glucose Monitoring) data with meal records, supporting postprandial blood glucose improvement and behavioral change through consultations with registered dietitians and AI utilization. By exhibiting and holding a seminar at this conference, we will widely disseminate implementation cases in medical institutions and scientific evidence.
■ Luncheon Seminar Outline
Date: Saturday, May 23rd, 2026, 12:00 PM - 12:50 PM
Venue: Osaka International Convention Center 3F, Event Hall S-9
Seating: 500 seats
A panel discussion of approximately 15 minutes is scheduled towards the end of the seminar. We will discuss how clinical insights and the potential of AI/mathematical analysis presented in each lecture can be utilized in daily clinical practice, providing practical suggestions that clinicians can apply from the next day's practice.
■ Exhibition Booth Outline
Venue: Osaka International Convention Center 3F, Event Hall S-9
Access: Grand Cube Osaka (Osaka International Convention Center)
At the booth, we will directly provide doctors and medical staff with concrete operational images in clinics and hospitals, focusing on use cases from medical institutions that have actually introduced our system. Trial applications and consultation for introduction will be accepted at any time.
■ Academic Mini-Seminar Outline
*Please note that the content, speakers, and times of each session are tentative and may be subject to change without prior notice due to circumstances. We appreciate your understanding.
■ About "glucose flight®︎"
Our health management service application, "glucose flight®︎," when used in conjunction with CGM, makes it possible to measure and digitize the factors of postprandial blood glucose fluctuations in relation to meal content and intake. Furthermore, it is equipped with a function that automatically generates diet and exercise recommendations to reduce disease risk.
Traditionally, guidance and treatment support for diabetic patients in the healthcare and medical fields tended to be uniform. However, by utilizing postprandial blood glucose fluctuation data, we expand the possibilities for personalized support and treatment tailored to each patient.
By applying the know-how gained from blood glucose data analysis to other biological data analysis, we aim to prevent the onset and severity of lifestyle-related diseases in general, and realize a healthy and prosperous society.
■ Company Profile
Company Name: THE PHAGE, Inc.
Representative: Shohei Tokunaga
Established: July 15, 2021
Location: VEIL SHIBUYA 2F, 2-16-8 Shibuya, Shibuya-ku, Tokyo
Business Activities: Development and provision of the postprandial blood glucose management platform "glucose flight®︎" / Deployment of digital health solutions utilizing Japan's first blood glucose foundational model / Joint research and R&D support with medical institutions, insurance companies, and government agencies
URL: https://thephage.life/
■ Contact for this matter
Public Relations: info@thephage.life
■ Background of Participation
In Japan, where approximately 10 million people are said to suffer from type 2 diabetes, optimizing HbA1c management is crucial. However, supporting behavioral changes to suppress postprandial hyperglycemia is also gaining attention as a vital pillar of treatment. Yet, visualizing patients' dietary habits and promoting continuous behavioral change within the time constraints of outpatient care remains a significant challenge.
Our "glucose flight®︎" platform integrates CGM (Continuous Glucose Monitoring) data with meal records, supporting postprandial blood glucose improvement and behavioral change through consultations with registered dietitians and AI utilization. By exhibiting and holding a seminar at this conference, we will widely disseminate implementation cases in medical institutions and scientific evidence.
■ Luncheon Seminar Outline
Date: Saturday, May 23rd, 2026, 12:00 PM - 12:50 PM
Venue: Osaka International Convention Center 3F, Event Hall S-9
Seating: 500 seats
A panel discussion of approximately 15 minutes is scheduled towards the end of the seminar. We will discuss how clinical insights and the potential of AI/mathematical analysis presented in each lecture can be utilized in daily clinical practice, providing practical suggestions that clinicians can apply from the next day's practice.
■ Exhibition Booth Outline
Venue: Osaka International Convention Center 3F, Event Hall S-9
Access: Grand Cube Osaka (Osaka International Convention Center)
At the booth, we will directly provide doctors and medical staff with concrete operational images in clinics and hospitals, focusing on use cases from medical institutions that have actually introduced our system. Trial applications and consultation for introduction will be accepted at any time.
■ Academic Mini-Seminar Outline
*Please note that the content, speakers, and times of each session are tentative and may be subject to change without prior notice due to circumstances. We appreciate your understanding.
■ About "glucose flight®︎"
Our health management service application, "glucose flight®︎," when used in conjunction with CGM, makes it possible to measure and digitize the factors of postprandial blood glucose fluctuations in relation to meal content and intake. Furthermore, it is equipped with a function that automatically generates diet and exercise recommendations to reduce disease risk.
Traditionally, guidance and treatment support for diabetic patients in the healthcare and medical fields tended to be uniform. However, by utilizing postprandial blood glucose fluctuation data, we expand the possibilities for personalized support and treatment tailored to each patient.
By applying the know-how gained from blood glucose data analysis to other biological data analysis, we aim to prevent the onset and severity of lifestyle-related diseases in general, and realize a healthy and prosperous society.
■ Company Profile
Company Name: THE PHAGE, Inc.
Representative: Shohei Tokunaga
Established: July 15, 2021
Location: VEIL SHIBUYA 2F, 2-16-8 Shibuya, Shibuya-ku, Tokyo
Business Activities: Development and provision of the postprandial blood glucose management platform "glucose flight®︎" / Deployment of digital health solutions utilizing Japan's first blood glucose foundational model / Joint research and R&D support with medical institutions, insurance companies, and government agencies
URL: https://thephage.life/
■ Contact for this matter
Public Relations: info@thephage.life